Deleted in Malignant Brain Tumors 1 is up-regulated in bacterial endocarditis and binds to components of vegetations  Hanna Müller, MD, Marcus Renner,

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 
Michael F. Nentwich, MD, Benjamin A. Bohn, MD, Faik G
Mycoplasma hominis prosthetic valve endocarditis: The value of molecular sequencing in cardiac surgery  Syed T. Hussain, MD, Steven M. Gordon, MD, Carmela.
Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves  Christopher G.A. McGregor, MB, FRCS, MD(Hons), Alain.
Extracorporeal membrane oxygenation for septic shock: Heroic futility?
Relationship between perioperative N-terminal pro-brain natriuretic peptide and maximum inotropic score in children after cardiac surgery  Yanqin Cui,
Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial.
Stem cells and bronchial stump healing
Cardiac surgery–associated neutrophil gelatinase–associated lipocalin score for postoperative acute kidney injury: What is the clinical implication? 
Building a bioartificial heart: A 3-song saga
Keratinocyte growth factor accelerates compensatory growth in the remaining lung after trilobectomy in rats  Keitaro Matsumoto, MD, Takeshi Nagayasu,
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
The Journal of Thoracic and Cardiovascular Surgery
Philippe Menasché, MD, PhD 
How should we treat air leaks?
Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation  Yosuke Tanaka, MD, Tomomi Hasegawa, MD, PhD,
Go on-pump or off-pump in diabetic patients?
Left atrial endocardial dysfunction and platelet activation in patients with atrial fibrillation and mitral stenosis  Zhi-Qiang Luo, MD, Xing-Hai Hao,
Activated protein C attenuates cardiopulmonary bypass–induced acute lung injury through the regulation of neutrophil activation  Sachiko Yamazaki, MD,
Cardiac stem cells in the real world
Daniel Schmauss, MD, Nicolas Gerber, MSc, Ralf Sodian, MD 
The lord of the rings  Antonio Miceli, MD, PhD 
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Rohit K. Singal, MD, MSc, FRCSC, Rakesh C. Arora, MD, PhD, FRCSC 
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections  Rumin He,
Military surgeons just want to have fun
A first start for lung transplantation?
Demonstration of persistent tumor cells 4 weeks after radiofrequency ablation of a pulmonary adenocarcinoma  Stéphane Renaud, Marco Schiavon, MD, Nicola.
Stephen R. Broderick, MD, MPHS 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Niv Ad, MD, Lawrence M. Wei, MD 
Attachment disorder in thoracoabdominal surgery
Case reporter's notebook: The who, what, when, where, how, and why of extraction of a benign intracaval tumor  Verdi J. DiSesa, MD, MBA  The Journal of.
Cardiac surgery in patients with a porcelain aorta
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
We are the company we keep: The importance of the tumor microenvironment  Sai Yendamuri, MD, FACS  The Journal of Thoracic and Cardiovascular Surgery 
Cardiac myxoma: Simplifying a “complex” case
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Nonintubated thoracoscopic surgery for pulmonary lesions in both lungs
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tissue valve, nitinol stent, or storage solution
The future of cardiac surgery training: A survival guide
Commentary: “Isn't cardiac surgery a team sport?”
Apparently, size matters…in congenital heart disease and brain injury
The continuing challenge of congenital heart disease in China
Giuseppe D'Ancona, MD, PhD, Hüseyin Ince, MD, PhD 
“The more things change…”: The challenges ahead
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Who should decide margin length in pulmonary excision of lung cancer?
Did you like Terminator 3 better than Terminator 2
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
A good chimney requires a good sweep
Journal changes and initiatives
Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD 
Deciding how much to pay for effective care
Presentation transcript:

Deleted in Malignant Brain Tumors 1 is up-regulated in bacterial endocarditis and binds to components of vegetations  Hanna Müller, MD, Marcus Renner, PhD, Burkhard M. Helmke, MD, Caroline End, PhD, Christel Weiss, PhD, Johannes Poeschl, MD, Jan Mollenhauer, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 138, Issue 3, Pages 725-732 (September 2009) DOI: 10.1016/j.jtcvs.2009.05.021 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Immunohistochemical analysis of DMBT1 in heart tissues of patients without and with bacterial endocarditis. Binding sites for anti-DMBT1p84 are shown as brown staining. A–D, Heart tissue without endocarditis of 1 case with staining score 0 (A, B, no. 7 in Table 1) and 1 case with staining score 1 (C, D, no. 6 in Table 1). E–H, Exemplary heart tissues of patients with endocarditis and less aggressive bacteria, with 1 case having a staining score of 0 (E, F, no. 25 in Table 1) and 1 case having a staining score of 1.5 (G, H, no. 24 in Table 1). I–L, Exemplary cardiac tissue of patients with endocarditis and aggressive bacteria. Both cases (I, J, no. 11 in Table 1 and K, L, no. 18 in Table 1) show a staining score of 3. I, J, Bacteria (thick arrows) and neutrophils (fine arrows) stain purple; DMBT1 is associated with bacteria and neutrophils. M, N (no. 14 in Table 1), Strong signals can be observed around localized atheromatosis. O, P (no. 14 in Table 1), Positive DMBT1 signals are found in granulocyte-depleted fibrin/fibrinogen (lower part), whereas granulocyte-rich fibrin/fibrinogen (upper part) remains negative. HE, Hematoxylin-eosin; DMBT1, deleted in malignant brain tumors 1. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 725-732DOI: (10.1016/j.jtcvs.2009.05.021) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Erythrocyte aggregation through hrDMBT1. Erythrocyte aggregation was measured for each individual blood preparation (n = 2–9 for the individual data points), and then the relative aggregation compared with the sample without addition of DMBT1 was calculated for each individual to account for interindividual differences. The diagram displays mean values and standard errors of the mean. Conc, Concentration; Li, lithium; hep, heparin; HrDMBT1, human recombinant deleted in malignant brain tumors 1. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 725-732DOI: (10.1016/j.jtcvs.2009.05.021) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 A, Analysis of DMBT1 binding to erythrocyte membranes. Lane 1: purified hrDMBT1 solved in PBS (positive control); lane 2: erythrocyte membranes incubated with hrDMBT1; lane 3: erythrocyte membranes without hrDMBT1 incubation (incubation with PBS only); lane 4: PBS washing solution extracted after the third washing step after hrDMBT1 incubation of the erythrocyte membranes. Lane 2 demonstrates binding of hrDMBT1 to erythrocyte membranes after hrDMBT1 incubation, whereas erythrocyte membranes without hrDMBT1 incubation showed no bound DMBT1. B, DMBT1 binding to platelets. Top: DMBT1 detection with the DMBT1-specific monoclonal antibody Hyb213-06. Bottom: detection of platelet/endothelial cell adhesion molecule (PECAM1) with a platelet/endothelial cell adhesion molecule–specific antibody as a control for equivalent loading amounts of platelets. Lane 1: purified hrDMBT1 solved in PBS serving as the positive control for DMBT1 detection; lane 2: platelets incubated with hrDMBT1; lane 3: platelets without hrDMBT1 incubation (incubation with PBS); lane 4: platelets incubated with hrDMBT1 after activation by thrombin in the presence of H-Gly-Pro-Arg-Pro-NH2 to prevent platelet aggregation; lane 5: platelets without hrDMBT1 incubation (incubation with PBS) after activation by thrombin in the presence of H-Gly-Pro-Arg-Pro-NH2 to prevent platelet aggregation; lane 6: PBS washing solution extracted after the third washing step after hrDMBT1 incubation of the platelets (lane 2); lane 7: PBS washing solution extracted after the third washing step after hrDMBT1 incubation of the activated platelets (lane 4). DMBT1 attaches to both nonactivated (lane 2) and activated platelets (lane 4) with no major differences. C, hrDMBT1 interacts with immobilized fibrinogen in a concentration-dependent manner. Control: experiments, in which hrDMBT1 incubation was omitted (negative control). Error bars are standard errors of the means. D, hrDMBT1 interacts with immobilized fibrin in a concentration-dependent manner. Control: experiments, in which hrDMBT1 incubation was omitted (negative control). Error bars are standard errors of the mean. DMBT1, Deleted in malignant brain tumors 1. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 725-732DOI: (10.1016/j.jtcvs.2009.05.021) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions